de Arruda M S, Fleury R N, Nogueira M E, Ura S, de Arruda O S
Departamento de Ciências Biológicas, Faculdade de Ciências, Universidade Estadual Paulista, Bauru, SP, Brasil.
Rev Soc Bras Med Trop. 1995 Jul-Sep;28(3):233-6. doi: 10.1590/s0037-86821995000300011.
In this study the immunopotentiator levamisole as well as a mixture of BCG/Mycobacterium leprae were investigated in inactive lepromatous leprosy patients by using the Mitsuda reaction as a parameter. Twenty lepromatous patients ten years ago classified as histologically negative for Mitsuda's test were divided into three groups: five patients that were only retested with Mitsuda antigen; eight patients that received oral levamisol and seven patients that received a mixture of alive BCG plus autoclaved M. leprae. The results indicated that: 1) the levamisole did not alter the reactivity to lepromin in any of the patients studied; 2) neither the changes in the reactivity to lepromin by using the mixture (3 cases) nor those that occurred spontaneously (3 cases) were clear. They properly reflected the natural variation of patients with some degree of resistance to Mycobacterium leprae.
在本研究中,以米氏反应作为参数,对免疫增强剂左旋咪唑以及卡介苗/麻风分枝杆菌混合物在静止期瘤型麻风患者中进行了研究。十年前组织学检查米氏试验阴性的20例瘤型患者被分为三组:5例仅再次用米氏抗原进行检测;8例口服左旋咪唑;7例接受活卡介苗加经高压灭菌的麻风分枝杆菌混合物。结果表明:1)左旋咪唑未改变所研究的任何患者对麻风菌素的反应性;2)使用混合物后对麻风菌素反应性的变化(3例)以及自发发生的变化(3例)均不明显。它们恰当地反映了对麻风分枝杆菌有一定程度抵抗力的患者的自然变异情况。